Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MaxSep: Meropenem vs Meropenem + Moxifloxacin in Severe Sepsis
NCT00534287Phase 3Completed
- Sponsor
- Kompetenznetz Sepsis
- Start
- Oct 2007
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin in sepsis, septic shock, sponsored by Kompetenznetz Sepsis. Started Oct 2007; status: completed.
02
Drugs
moxifloxacin
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT00534287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534287.